SIHUAN PHARM Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
• Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
Market: HKEX |
Currency: HKD
Address: Office Tower, Convention Plaza
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, and biotechnology and technology promotion services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Show more
📈 SIHUAN PHARM Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$2.30
-
Upside/Downside from Analyst Target:
71.67%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
2026-08-28
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for SIHUAN PHARM
| Date | Reported EPS |
|---|
| 2026-08-28 (estimated upcoming) | - |
📰 Latest Corporate News
March 24, 2026 7:47 pm | HKEX
Sihuan Pharmaceutical: BRIGHT-2 Phase 3 Results Published in...
March 8, 2026 6:12 pm | HKEX
Sihuan Pharmaceutical Holdings Group Ltd. Announces Inclusio...
March 3, 2026 4:43 pm | HKEX
Sihuan Pharmaceutical: Key Milestone in Breast Cancer Drug A...
November 30, -0001 12:00 am | HKEX
Sihuan Pharmaceutical Holdings Group Ltd. - Xuanzhu Biopharm...
📰 Related News & Research
🔍 View more Reports